Vaxart to Present Research on Second-Generation Norovirus Oral Pill Vaccine Candidate at IDWeek 2025

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it ...

Over 100 students fall ill with norovirus in Shandong’s Binzhou: statement

More than 100 students at Binzhou vocational college in East China's Shandong Province have been diagnosed with norovirus ...